MyFinsight
Home
Blog
About
Contact
Marketable securities
$5,791,100K
(10.11%↑ Y/Y)
Accounts receivable, net
$5,731,000K
(3.06%↑ Y/Y)
Inventories
$3,103,600K
(-2.78%↓ Y/Y)
Cash and cash
equivalents
$2,962,600K
(-4.13%↓ Y/Y)
Prepaid expenses and
other current assets
$620,900K
(32.42%↑ Y/Y)
Total current assets
$18,209,200K
(3.63%↑ Y/Y)
Marketable securities
$9,786,000K
(5.49%↑ Y/Y)
Property, plant, and
equipment, net
$5,266,100K
(12.18%↑ Y/Y)
Deferred tax assets
$4,190,900K
(21.73%↑ Y/Y)
Other noncurrent
assets
$2,129,700K
(52.87%↑ Y/Y)
Intangible assets, net
$1,286,900K
(10.27%↑ Y/Y)
Total assets
$40,868,800K
(8.85%↑ Y/Y)
Total liabilities and
stockholders' equity
$40,868,800K
(8.85%↑ Y/Y)
Total stockholders'
equity
$31,423,600K
(6.93%↑ Y/Y)
Total liabilities
$9,445,200K
(15.78%↑ Y/Y)
Treasury stock, at cost
34.7 shares in 2026...
$19,413,500K
(19.70%↑ Y/Y)
Retained earnings
$36,423,800K
(12.47%↑ Y/Y)
Total current
liabilities
$5,107,700K
(43.21%↑ Y/Y)
Other noncurrent
liabilities
$2,126,200K
(26.98%↑ Y/Y)
Long-term debt
$1,986,200K
(0.07%↑ Y/Y)
Deferred revenue
$225,100K
(6.28%↑ Y/Y)
Additional paid-in capital
$14,401,300K
(9.17%↑ Y/Y)
Accumulated other
comprehensive income
$11,900K
(-59.11%↓ Y/Y)
Common stock-Common
Stock
$100K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$2,724,400K
(21.53%↑ Y/Y)
Accounts payable
$1,027,100K
(45.58%↑ Y/Y)
Finance lease
liabilities
$720,000K
(0.00%↑ Y/Y)
Deferred revenue
$636,200K
(2.73%↑ Y/Y)
Back
Back
Balance Sheet
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
source: myfinsight.com